TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators May 3, 1974
TCL Archive In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC July 2, 1999
